Paternal retraction of a fragile X allele to normal size, showing normal function over two generations

The FMR1 premutation (PM:55‐199 CGG) is associated with fragile X‐associated tremor/ataxia syndrome (FXTAS) and when maternally transmitted is at risk of expansion to a hypermethylated full mutation (FM: ≥ 200 CGG) that causes fragile X syndrome (FXS). We describe a maternally transmitted PM (77 CGG) that was passed to a son (103 CGG), and to a daughter (220–1822 CGG), who were affected with FXTAS and FXS, respectively. The male with the PM showed low‐level mosaicism for normal size of 30 and 37 CGG. This male had two offspring: one female mosaic for PM and FM (56, 157, >200 CGG) and another with only a 37 CGG allele detected in multiple tissues, neither with a clinical phenotype. The female with the 37 CGG allele showed normal levels of FMR1 methylation and mRNA and passed this 37 CGG allele to one of her daughters, who was also unaffected. These findings show that post‐zygotic paternal retraction can lead to low‐level mosaicism for normal size alleles, with these normal alleles being functional when passed over two generations.

[1]  M. Field,et al.  DNA Methylation at Birth Predicts Intellectual Functioning and Autism Features in Children with Fragile X Syndrome , 2020, International journal of molecular sciences.

[2]  V. Faundes,et al.  FMR1 mRNA from full mutation alleles is associated with ABC-CFX scores in males with fragile X syndrome , 2020, Scientific Reports.

[3]  M. Genuardi,et al.  Reversion to Normal of FMR1 Expanded Alleles: A Rare Event in Two Independent Fragile X Syndrome Families , 2020, Genes.

[4]  D. Francis,et al.  Abnormally Methylated FMR1 in Absence of a Detectable Full Mutation in a U.S.A Patient Cohort Referred for Fragile X Testing , 2019, Scientific Reports.

[5]  T. Dudding-Byth,et al.  Significantly Elevated FMR1 mRNA and Mosaicism for Methylated Premutation and Full Mutation Alleles in Two Brothers with Autism Features Referred for Fragile X Testing , 2019, International journal of molecular sciences.

[6]  A. Vianna-Morgante,et al.  Expansions and contractions of the FMR1 CGG repeat in 5,508 transmissions of normal, intermediate, and premutation alleles , 2019, American journal of medical genetics. Part A.

[7]  C. Bagni,et al.  A Synaptic Perspective of Fragile X Syndrome and Autism Spectrum Disorders , 2019, Neuron.

[8]  M. Fahey,et al.  Prenatal Diagnosis of Fragile X Syndrome in a Twin Pregnancy Complicated by a Complete Retraction , 2018, Genes.

[9]  C. Dissanayake,et al.  Intragenic DNA methylation in buccal epithelial cells and intellectual functioning in a paediatric cohort of males with fragile X , 2018, Scientific Reports.

[10]  M. Milá,et al.  Paternal transmission of a FMR1 full mutation allele , 2017, American journal of medical genetics. Part A.

[11]  Q. Bui,et al.  β-glucuronidase mRNA levels are correlated with gait and working memory in premutation females: understanding the role of FMR1 premutation alleles , 2016, Scientific Reports.

[12]  V. Faundes,et al.  Identification of Males with Cryptic Fragile X Alleles by Methylation-Specific Quantitative Melt Analysis. , 2016, Clinical chemistry.

[13]  Z. Stark,et al.  Prenatal diagnosis of fragile X syndrome complicated by full mutation retraction , 2015, American journal of medical genetics. Part A.

[14]  W. Brown,et al.  Fragile X full mutation expansions are inhibited by one or more AGG interruptions in premutation carriers , 2014, Genetics in Medicine.

[15]  D. Loesch,et al.  Early detection of fragile X syndrome: applications of a novel approach for improved quantitative methylation analysis in venous blood and newborn blood spots. , 2014, Clinical chemistry.

[16]  D. Loesch,et al.  Fragile X–related element 2 methylation analysis may provide a suitable option for inclusion of fragile X syndrome and/or sex chromosome aneuploidy into newborn screening: a technical validation study , 2012, Genetics in Medicine.

[17]  D. Francis,et al.  Identification of Small FRAXA Premutations , 2000, Molecular Diagnosis.

[18]  P. Hagerman,et al.  High-resolution methylation polymerase chain reaction for fragile X analysis: Evidence for novel FMR1 methylation patterns undetected in Southern blot analyses , 2011, Genetics in Medicine.

[19]  D. Loesch,et al.  Evidence for the toxicity of bidirectional transcripts and mitochondrial dysfunction in blood associated with small CGG expansions in the FMR1 gene in patients with parkinsonism , 2011, Genetics in Medicine.

[20]  Weimin Sun,et al.  Qualitative assessment of FMR1 (CGG)n triplet repeat status in normal, intermediate, premutation, full mutation, and mosaic carriers in both sexes: Implications for fragile X syndrome carrier and newborn screening , 2010, Genetics in Medicine.

[21]  D. Loesch,et al.  Methylation of novel markers of fragile X alleles is inversely correlated with FMRP expression and FMR1 activation ratio. , 2010, Human molecular genetics.

[22]  M. Khaniani,et al.  An improved Diagnostic PCR Assay for identification of Cryptic Heterozygosity for CGG Triplet Repeat Alleles in the Fragile X Gene (FMR1) , 2008, Molecular Cytogenetics.

[23]  L. Zwaigenbaum,et al.  Paternal transmission of fragile X syndrome , 2004, American journal of medical genetics. Part A.

[24]  L Zhang,et al.  Fragile-X-associated tremor/ataxia syndrome (FXTAS) in females with the FMR1 premutation. , 2004, American journal of human genetics.

[25]  P. Jin,et al.  Understanding the molecular basis of fragile X syndrome. , 2000, Human molecular genetics.

[26]  T. Godfrey,et al.  Elevated levels of FMR1 mRNA in carrier males: a new mechanism of involvement in the fragile-X syndrome. , 2000, American journal of human genetics.

[27]  J. Mandel,et al.  The FMR–1 protein is cytoplasmic, most abundant in neurons and appears normal in carriers of a fragile X premutation , 1993, Nature Genetics.